The 22q11.2 microdeletion: Fifteen years of insights into the genetic and neural complexity of psychiatric disorders
Tóm tắt
Over the last fifteen years it has become established that 22q11.2 deletion syndrome (22q11DS) is a true genetic risk factor for schizophrenia. Carriers of deletions in chromosome 22q11.2 develop schizophrenia at rate of 25–30% and such deletions account for as many as 1–2% of cases of sporadic schizophrenia in the general population. Access to a relatively homogeneous population of individuals that suffer from schizophrenia as the result of a shared etiological factor and the potential to generate etiologically valid mouse models provides an immense opportunity to better understand the pathobiology of this disease. In this review we survey the clinical literature associated with the 22q11.2 microdeletions with a focus on neuroanatomical changes. Then, we highlight results from work modeling this structural mutation in animals. The key biological pathways disrupted by the mutation are discussed and how these changes impact the structure and function of neural circuits is described.
Từ khóa
Tài liệu tham khảo
Akbarian S., 1996, Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients, Arch. Gen. Psychiatry, 53, 425, 10.1001/archpsyc.1996.01830050061010
Antshel K.M., 2005, Behavior and corpus callosum morphology relationships in velocardiofacial syndrome (22q11.2 deletion syndrome), Psychiatry Res., 138, 235, 10.1016/j.pscychresns.2005.02.003
Arguello P.A., 2006, Modeling madness in mice: one piece at a time, Neuron, 52, 179, 10.1016/j.neuron.2006.09.023
Arguello P.A., 2010, Cognition in mouse models of schizophrenia susceptibility genes, Schizophr. Bull., 36, 289, 10.1093/schbul/sbp153
Arguello P.A., 2010, Development of animal models for schizophrenia, Dis. Model Mech., 3, 22, 10.1242/dmm.003996
Aultman J.M., 2001, Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task, Psychopharmacology, 153, 353, 10.1007/s002130000590
Axelrod J., 1958, Enzymatic O‐methylation of epinephrine and other catechols, J. Biol. Chem., 233, 702, 10.1016/S0021-9258(18)64731-3
Babovic D., 2008, Phenotypic characterization of cognition and social behavior in mice with heterozygous versus homozygous deletion of catechol‐O‐methyltransferase, Neuroscience, 155, 1021, 10.1016/j.neuroscience.2008.07.006
Baker K., 2005, COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome, Biol. Psychiatry, 58, 23, 10.1016/j.biopsych.2005.03.020
Barnea‐Goraly N., 2003, Investigation of white matter structure in velocardiofacial sndrome: a diffusion tensor imaging study, Am. J. Psychiatry, 160, 1863, 10.1176/appi.ajp.160.10.1863
Barnea‐Goraly N., 2005, Arithmetic ability and parietal alterations: a diffusion tensor imaging study in velocardiofacial syndrome, Brain Res. Cogn. Brain Res., 25, 735, 10.1016/j.cogbrainres.2005.09.013
Bassett A.S., 1998, 22q11 deletion syndrome in adults with schizophrenia, Am. J. Med. Genet., 81, 328, 10.1002/(SICI)1096-8628(19980710)81:4<328::AID-AJMG10>3.0.CO;2-N
Bassett A.S., 2003, The schizophrenia phenotype in 22q11 deletion syndrome, Am. J. Psychiatry, 160, 1580, 10.1176/appi.ajp.160.9.1580
Bearden C.E., 2001, The neurocognitive phenotype of the 22q11.2 deletion syndrome: selective deficit in visual‐spatial memory, J. Clin. Exp. Neuropsychol., 23, 447, 10.1076/jcen.23.4.447.1228
Bearden C.E., 2007, Mapping cortical thickness in children with 22q11.2 deletions, Cereb. Cortex, 17, 1889, 10.1093/cercor/bhl097
Bearden C.E., 2009, Alterations in midline cortical thickness and gyrification patternsmapped in children with 22q11.2 deletions, Cereb. Cortex, 19, 115, 10.1093/cercor/bhn064
Belforte J.E., 2010, Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia‐like phenotypes, Nat. Neurosci., 13, 76, 10.1038/nn.2447
Benchenane K., 2010, Coherent theta oscillations and reorganization of spike timing in the hippocampal‐prefrontal network upon learning, Neuron, 66, 921, 10.1016/j.neuron.2010.05.013
Bender H.U., 2005, Functional consequences of PRODH missense mutations, Am. J. Hum. Genet., 76, 409, 10.1086/428142
Bish J.P., 2004, Thalamic reductions in children with chromosome 22q11.2 deletion syndrome, Neuroreport, 15, 1413, 10.1097/01.wnr.0000129855.50780.85
Bish J.P., 2005, Maladaptive conflict monitoring as evidence for executive dysfunction in children with chromosome 22q11.2 deletion syndrome, Dev. Sci., 8, 36, 10.1111/j.1467-7687.2005.00391.x
Bish J.P., 2006, Specific cerebellar reductions in children with chromosome 22q11.2 deletion syndrome, Neurosci. Lett., 399, 245, 10.1016/j.neulet.2006.02.001
Bish J.P., 2007, Domain specific attentional impairments in children with chromosome 22q11.2 deletion syndrome, Brain Cogn., 64, 265, 10.1016/j.bandc.2007.03.007
Bittel D.C., 2009, Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH, Cytogenet. Genome Res., 124, 113, 10.1159/000207515
Buzsáki G., 2004, Large‐scale recording of neuronal ensembles, Nat. Neurosci., 7, 446, 10.1038/nn1233
Campbell L.E., 2006, Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel‐based morphometry MRI study, Brain, 129, 1218, 10.1093/brain/awl066
Cantz T., 2008, In vitro differentiation of reprogrammed murine somatic cells into hepatic precursor cells, Biol. Chem., 389, 889, 10.1515/BC.2008.107
Carlson C., 1997, Molecular definition of 22q11 deletions in 151 velo‐cardio‐facial syndrome patients, Am. J. Hum. Genet., 61, 620, 10.1086/515508
Chow E.W.C., 1999, Qualitative MRI findings in adults with 22q11 Deletion Syndrome and schizophrenia, Biol. Psychiatry, 46, 1436, 10.1016/S0006-3223(99)00150-X
Chow E.W.C., 2002, Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome, Biol. Psychiatry, 51, 208, 10.1016/S0006-3223(01)01246-X
Chow E.W., 2006, Neurocognitive profile in 22q11 deletion syndrome and schizophrenia, Schizophr. Res., 87, 270, 10.1016/j.schres.2006.04.007
Corbetta M., 2002, Control of goal‐directed and stimulus‐driven attention in the brain, Nat. Rev. Neurosci., 3, 201, 10.1038/nrn755
Davies B., 1993, Physiological parameters in laboratory animals and humans, Pharm. Res., 10, 1093, 10.1023/A:1018943613122
Day R., 1987, Stressful life events preceding the acute onset of schizophrenia: a cross national study from the World Health Organisation, Cult. Med. Soc., 11, 123
De Smedt B., 2007, Mathematical disabilities in children with velo‐cardio‐facial syndrome, Neuropsychologia, 45, 885, 10.1016/j.neuropsychologia.2006.08.024
Debbané M., 2005, Temporal perception in velo‐cardio facial syndrome, Neuropsychologia, 43, 1754, 10.1016/j.neuropsychologia.2005.02.006
Debbané M., 2006, Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications, Schizophr. Res., 84, 187, 10.1016/j.schres.2006.01.019
Debbané M., 2006, Hippocampal volume reduction in 22q11.2 deletion syndrome, Neuropsychologia, 44, 2360, 10.1016/j.neuropsychologia.2006.05.006
Deng J., 2009, Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming, Nat. Biotechnol., 27, 353, 10.1038/nbt.1530
Dickinson D., 2009, Genes, cognition and brain through a COMT lens, Neuroscience, 164, 72, 10.1016/j.neuroscience.2009.05.014
Dimos J.T., 2008, Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons, Science, 321, 1218, 10.1126/science.1158799
Ebert A.D., 2009, Induced pluripotent stem cells from a spinal muscular atrophy patient, Nature, 457, 277, 10.1038/nature07677
Edelmann L., 1999, Low‐copy repeats mediate the common 3‐Mb deletion in patients with velo‐cardio‐facial syndrome, Am. J. Hum. Genet., 64, 1076, 10.1086/302343
Eiraku M., 2008, Self‐organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals, Cell Stem Cell, 3, 519, 10.1016/j.stem.2008.09.002
el‐Husseini A.D., 2002, Protein palmitoylation: a regulator of neuronal development and function, Nat. Rev. Neurosci., 3, 791, 10.1038/nrn940
Eliez S., 2000, Children and adolescents with velocardiofacial syndrome: a volumetric MRI study, Am. J. Psychiatry, 157, 409, 10.1176/appi.ajp.157.3.409
Eliez S., 2001, Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia?, Am. J. Psychiatry, 158, 447, 10.1176/appi.ajp.158.3.447
Eliez S., 2001, A quantitative MRI study of posterior fossa development in velocardiofacial syndrome, Biol. Psychiatry, 49, 540, 10.1016/S0006-3223(00)01005-2
Eliez S., 2002, Increased basal ganglia volumes in velo‐cardio‐facial syndrome (Deletion 22q11.2), Biol. Psychiatry, 52, 68, 10.1016/S0006-3223(02)01361-6
Elvevag B., 2000, Cognitive impairment in schizophrenia is the core of the disorder, Crit. Rev. Neurobiol., 14, 1, 10.1615/CritRevNeurobiol.v14.i1.10
Feinstein C., 2002, Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk, Biol. Psychiatry, 51, 312, 10.1016/S0006-3223(01)01231-8
Feng G., 2000, Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP, Neuron, 28, 41, 10.1016/S0896-6273(00)00084-2
Fiore R., 2009, Mef2‐mediated transcription of the miR379‐410 cluster regulates activity‐dependent dendritogenesis by fine‐tuning Pumilio2 protein levels, EMBO J., 28, 697, 10.1038/emboj.2009.10
Fletcher P.C., 2009, Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia, Nat. Rev. Neurosci., 10, 48, 10.1038/nrn2536
Foong J., 2000, Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study, J. Neurol. Neurosurg. Psychiatry, 68, 242, 10.1136/jnnp.68.2.242
Foong J., 2001, Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging, Brain, 124, 882, 10.1093/brain/124.5.882
Ford J.M., 2002, Reduced communication between frontal and temporal lobes during talking in schizophrenia, Biol. Psychiatry, 51, 485, 10.1016/S0006-3223(01)01335-X
Fremeau R.T., 1992, Molecular cloning and expression of a high affinity L‐proline transporter expressed in putative glutamatergic pathways of rat brain, Neuron, 8, 915, 10.1016/0896-6273(92)90206-S
Friston K.J., 1996, Functional topography: multidimensional scaling and functional connectivity in the brain, Cereb. Cortex, 6, 156, 10.1093/cercor/6.2.156
Fukata M., 2004, Identification of PSD‐95 palmitoylating enzymes, Neuron, 44, 987, 10.1016/j.neuron.2004.12.005
Fukata Y., 2010, Protein palmitoylation in neuronal development and synaptic plasticity, Nat. Rev. Neurosci., 11, 161, 10.1038/nrn2788
Gaspard N., 2008, An intrinsic mechanism of corticogenesis from embryonic stem cells, Nature, 455, 351, 10.1038/nature07287
Glaser B., 2008, Structural changes to the fusiform gyrus: a cerebral marker for social impairments in 22q11. 2 deletion syndrome?, Schizophr. Res., 96, 82
Gogos J.A., 1998, Catechol‐O‐methyltransferase‐deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior, Proc. Natl. Acad. Sci. U.S.A., 95, 9991, 10.1073/pnas.95.17.9991
Gogos J.A., 1999, The gene encoding proline dehydrogenase modulates sensorimotor gating in mice, Nat. Genet., 21, 434, 10.1038/7777
Gothelf D., 2005, COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome, Nat. Neurosci., 8, 1500, 10.1038/nn1572
Gothelf D., 2007, Risk factors for the emergence of psychotic disorders in adolescents with 22q11. 2 deletion syndrome, Am. J. Psychiatry, 164, 663, 10.1176/ajp.2007.164.4.663
Gothelf D., 2007, Developmental trajectories of brain structure in adolescents with 22q11. 2 deletion syndrome: a longitudinal study, Schizophr. Res., 96, 72, 10.1016/j.schres.2007.07.021
Gothelf D., 2008, Genes, brain development and psychiatric phenotypes in velo‐cardio‐facial syndrome, Dev. Dis. Res. Rev., 14, 59, 10.1002/ddrr.9
Gratton G., 1992, Optimizing the use of information: strategic control of activation of responses, J. Exp. Psychol. Gen., 121, 480, 10.1037/0096-3445.121.4.480
Green M.F., 2000, Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?, Schizophr. Bull., 26, 119, 10.1093/oxfordjournals.schbul.a033430
Green M.F., 2004, For clinical trials in schizophrenia: the NIMH‐MATRICS conference to select cognitive domains and test criteria, Biol. Psychiatry, 56, 301, 10.1016/j.biopsych.2004.06.023
Gulledge A.T., 2005, Synaptic integration in dendritic trees, J. Neurobiol., 64, 75, 10.1002/neu.20144
Han J., 2009, Posttranscriptional crossregulation between Drosha and DGCR8, Cell, 136, 75, 10.1016/j.cell.2008.10.053
Hasenkamp W., 2010, Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families, Psychiatry Res., 178, 236, 10.1016/j.psychres.2009.11.012
Henzi V., 1992, L‐proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons, Mol. Pharmacol., 41, 793
Hobert O., 2008, Gene regulation by transcription factors and microRNAs, Science, 319, 1785, 10.1126/science.1151651
Hockemeyer D., 2009, Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc‐finger nucleases, Nat. Biotechnol., 27, 851, 10.1038/nbt.1562
Hotta A., 2009, Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency, Nat. Methods, 6, 370, 10.1038/nmeth.1325
Howes O.D., 2009, The dopamine hypothesis of schizophrenia: version III—the final common pathway, Schizophr. Bull., 35, 549, 10.1093/schbul/sbp006
Huotari M., 2002, Brain catecholamine metabolism in catechol‐O‐methyltransferase (COMT)‐deficient mice, Eur. J. Neurosci., 15, 246, 10.1046/j.0953-816x.2001.01856.x
Hutvagner G., 2001, A cellular function for the RNA‐interference enzyme Dicer in the maturation of the let‐7 small temporal RNA, Science, 293, 834, 10.1126/science.1062961
Ideguchi M., 2010, Murine embryonic stem cell‐derived pyramidal neurons integrate into the cerebral cortex and appropriately project axons to subcortical targets, J. Neurosci., 30, 894, 10.1523/JNEUROSCI.4318-09.2010
Inta D., 2010, Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review, Neurosci. Biobehav. Rev., 34, 285, 10.1016/j.neubiorev.2009.07.010
Jacquet H., 2002, PRODH mutations and hyperprolinemia in a subset of schizophrenic patients, Hum. Mol. Genet., 11, 2243, 10.1093/hmg/11.19.2243
Jerome L.A., 2001, DiGeorge syndrome phenotype in mice mutant for the T‐box gene Tbx1, Nat. Genet., 27, 286, 10.1038/85845
Jones M.W., 2002, A comparative review of rodent prefrontal cortex and working memory, Curr. Mol. Med., 2, 639, 10.2174/1566524023361989
Kadener S., 2009, Genome‐wide identification of targets of the drosha‐pasha/DGCR8 complex, RNA, 15, 537, 10.1261/rna.1319309
Karayiorgou M., 1995, Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11, Proc. Natl. Acad. Sci. U.S.A., 92, 7612, 10.1073/pnas.92.17.7612
Karayiorgou M., 2004, The molecular genetics of the 22q11‐associated schizophrenia, Brain Res. Mol. Brain Res., 132, 95, 10.1016/j.molbrainres.2004.09.029
Karayiorgou M., 2010, 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia, Nat. Rev. Neurosci., 11, 402, 10.1038/nrn2841
Kates W.R., 2001, Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis, Biol. Psychiatry, 49, 677, 10.1016/S0006-3223(00)01002-7
Kates W.R., 2004, Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2, J. Child Neurol., 19, 337, 10.1177/088307380401900506
Kates W.R., 2006, Temporal lobe anatomy and psychiatric symptoms in velocardiofacial syndrome (22q11.2 deletion syndrome), J. Am. Acad. Child Adolesc. Psychiatry, 45, 587, 10.1097/01.chi.0000205704.33077.4a
Kates W.R., 2007, The neural correlates of non‐spatial working memory in velocardiofacial syndrome (22q11.2 deletion syndrome), Neuropsychologia, 45, 2863, 10.1016/j.neuropsychologia.2007.05.007
Kellendonk C., 2006, Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning, Neuron, 49, 603, 10.1016/j.neuron.2006.01.023
Kimber W.L., 1999, Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse, Hum. Mol. Genet., 8, 2229, 10.1093/hmg/8.12.2229
Kobrynski L.J., 2007, Velocardiofacial syndrome. DiGeorge syndrome: the chromosome 22q11. 2 deletion syndromes, Lancet, 370, 1443, 10.1016/S0140-6736(07)61601-8
Kubicki M., 2002, Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study, Am. J. Psychiatry, 159, 813, 10.1176/appi.ajp.159.5.813
Kurahashi H., 2000, Regions of genomic instability on 22q11 and 11q23 as the etiology for the recurrent constitutional t(11;22), Hum. Mol. Genet., 9, 1665, 10.1093/hmg/9.11.1665
Kuzmenkin A., 2009, Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro, FASEB J., 23, 4168, 10.1096/fj.08-128546
Kwon J.S., 1998, MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder, Am. J. Psychiatry, 155, 509, 10.1176/ajp.155.4.509
Lajiness‐O'Neill R.R., 2005, Memory and learning in children with 22q11. 2 deletion syndrome: evidence for ventral and dorsal stream disruption?, Child Neuropsychol., 11, 55, 10.1080/09297040590911202
Lawrie S.M., 2002, Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations, Biol. Psychiatry, 51, 1008, 10.1016/S0006-3223(02)01316-1
Lee I., 2003, Time‐dependent relationship between the dorsal hippocampus and the prefrontal cortex in spatial memory, J. Neurosci., 23, 1517, 10.1523/JNEUROSCI.23-04-01517.2003
Lee G., 2009, Modelling pathogenesis and treatment of familial dysautonomia using patient‐specific iPSCs, Nature, 461, 402, 10.1038/nature08320
Lewis D.A., 2005, Cortical inhibitory neurons and schizophrenia, Nat. Rev. Neurosci., 6, 312, 10.1038/nrn1648
Linder M.E., 2004, Model organisms lead the way to protein palmitoyl‐transferases, J. Cell Sci., 117, 521, 10.1242/jcs.00989
Lindsay E.A., 1999, Congenital heart disease in mice deficient for the DiGeorge syndrome region, Nature, 401, 379, 10.1038/43900
Lindsay E.A., 2001, Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice, Nature, 410, 97, 10.1038/35065105
Liu H., 2002, Karayiorgou M.Genetic variation in the 22q11 locus and susceptibility to schizophrenia, Proc. Natl. Acad. Sci. U.S.A., 99, 16859, 10.1073/pnas.232186099
Liu H., 2002, Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia, Proc. Natl. Acad. Sci. U.S.A., 99, 3717, 10.1073/pnas.042700699
Lodge D.J., 2008, Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia, Neurotox. Res., 14, 97, 10.1007/BF03033801
Long J.M., 2006, Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome, Neurogenetics, 7, 247, 10.1007/s10048-006-0054-0
Lugli G., 2008, Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain, J. Neurochem., 106, 650, 10.1111/j.1471-4159.2008.05413.x
Lundström K., 1995, Cloning, expression and structure of catechol‐O‐methyltransferase, Biochim. Biophys. Acta, 1251, 1, 10.1016/0167-4838(95)00071-2
Machado A.M., 2007, Corpus callosum morphology and ventricular size in chromodome 22q11.2 deletion syndrome, Brain Res., 1131, 197, 10.1016/j.brainres.2006.10.082
Matsumoto M., 2003, Catechol O‐methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function, Neuroscience, 116, 127, 10.1016/S0306-4522(02)00556-0
Maynard T.M., 2003, A comprehensive analysis of 22q11 gene expression in the developing and adult brain, Proc. Natl. Acad. Sci. U.S.A., 100, 14433, 10.1073/pnas.2235651100
Meechan D.W., 2009, Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome, Proc. Natl. Acad. Sci. U.S.A., 106, 16434, 10.1073/pnas.0905696106
Merscher S., 2001, TBX1 is responsible for cardiovascular defects in velo‐cardio‐facial/DiGeorge syndrome, Cell, 104, 619, 10.1016/S0092-8674(01)00247-1
Meyer‐Lindenberg A.S., 2005, Regionally specific disturbance of dorsolateral prefrontal‐hippocampal functional connectivity in schizophrenia, Arch. Gen. Psychiatry, 62, 379, 10.1001/archpsyc.62.4.379
Meyer‐Lindenberg A., 2006, Intermediate phenotypes and genetic mechanisms of psychiatric disorders, Nat. Rev. Neurosci., 7, 818, 10.1038/nrn1993
Millar J.K., 2000, Disruption of two novel genes by a translocation co‐segregating with schizophrenia, Hum. Mol. Genet., 9, 1415, 10.1093/hmg/9.9.1415
Moncrieff J., 2009, A critique of the dopamine hypothesis of schizophrenia and psychosis, Harv. Rev. Psychiatry, 17, 214, 10.1080/10673220902979896
Moss E.M., 1999, Psychoeducational profile of the 22q11.2 microdeletion: a complex pattern, J. Pediatr., 134, 193, 10.1016/S0022-3476(99)70415-4
Mukai J., 2004, Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia, Nat. Genet., 36, 725, 10.1038/ng1375
Mukai J., 2008, Palmitoylation‐dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion, Nat. Neurosci., 11, 1302, 10.1038/nn.2204
Murphy K.C., 1999, High rates of schizophrenia in adults with velo‐cardio‐facial syndrome, Arch. Gen. Psychiatry, 56, 940, 10.1001/archpsyc.56.10.940
Nadler J.V., 1988, Toxicity of L‐proline toward rat hippocampal neurons, Brain Res., 456, 168, 10.1016/0006-8993(88)90358-7
Nopoulos P., 1997, Cavum septi pellucidi in normals and patients with schizophrenia as detected by magnetic resonance imaging, Biol. Psychiatry, 41, 1102, 10.1016/S0006-3223(96)00209-0
Obernosterer G., 2006, Post‐transcriptional regulation of microRNA expression, RNA, 12, 1161, 10.1261/rna.2322506
Papaleo F., 2008, Genetic dissection of the role of catechol‐O‐methyltransferase in cognition and stress reactivity in mice, J. Neurosci., 28, 8709, 10.1523/JNEUROSCI.2077-08.2008
Park I.H., 2008, Disease‐specific induced pluripotent stem cells, Cell, 134, 877, 10.1016/j.cell.2008.07.041
Paterlini M., 2005, Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia‐related phenotypes in mice, Nat. Neurosci., 8, 1586, 10.1038/nn1562
Paylor R., 2001, Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments, Hum. Mol. Genet., 10, 2645, 10.1093/hmg/10.23.2645
Paylor R., 2006, Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome, Proc. Natl. Acad. Sci. U.S.A., 103, 7729, 10.1073/pnas.0600206103
Perkins D.O., 2007, microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder, Genome Biol., 8, R27, 10.1186/gb-2007-8-2-r27
Pfefferbaum A., 1991, Neuroimaging studies of schizophrenia, Schizophr. Res., 4, 193, 10.1016/0920-9964(91)90033-N
Phang J.M., 2001, Disorders of Proline and Hydoxyproline Metabolism; The Metabolic and Molecular and Bases of Inherited Disease, 8e
PhangJ.M. LiuW. ZabirnykO. 2010.Proline metabolism and microenvironmental stress. Annu. Rev. Nutr. April 23 (Epub ahead of print).
Portnoï M.F., 2009, Microduplication 22q11.2: a new chromosomal syndrome, Eur. J. Med. Genet., 52, 88, 10.1016/j.ejmg.2009.02.008
Puech A., 2000, Normal cardiovascular development in mice deficient for 16 genes in 550 kb of the velocardiofacial/DiGeorge syndrome region, Proc. Natl. Acad. Sci. U.S.A., 97, 10090, 10.1073/pnas.97.18.10090
Pulver A.E., 1994, Psychotic illness in patients diagnosed with velo‐cardio‐facial syndrome and their relatives, J. Nerv. Ment. Dis., 182, 476, 10.1097/00005053-199408000-00010
Ramachandran V., 2008, Degradation of microRNAs by a family of exoribonucleases in Arabidopsis, Science, 321, 1490, 10.1126/science.1163728
Raux G., 2007, Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome, Hum. Mol. Genet., 16, 83, 10.1093/hmg/ddl443
Robin N.H., 2006, Polymicrogyria and deletion 22q11.2 syndrome: Window to the etiology of a common cortical malformation, Am. J. Med. Genet. Part A, 140, 2416, 10.1002/ajmg.a.31443
Ryan A.K., 1997, Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study, J. Med. Genet., 34, 798, 10.1136/jmg.34.10.798
Schenke‐Layland K., 2008, Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages, FASEB J., 23, 4168
Schratt G.M., 2006, A brain‐specific microRNA regulates dendritic spine development, Nature, 439, 283, 10.1038/nature04367
Shaikh T.H., 2000, Chromosome 22‐specific low copy repeats and the 22q11. 2 deletion syndrome: genomic organization and deletion endpoint analysis, Hum. Mol. Genet., 9, 489, 10.1093/hmg/9.4.489
Shashi V., 2004, Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome, Neuroimage, 21, 1399, 10.1016/j.neuroimage.2003.12.004
Shashi V., 2010, Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome, Psychiatry Res., 181, 1, 10.1016/j.pscychresns.2009.07.003
Shelton R.C., 1986, The Neurology of Schizophrenia, 207
Shprintzen R.J., 1978, A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo‐cardio‐facial syndrome, Cleft Palate J., 15, 56
Shprintzen R.J., 1992, Late onset psychosis in the velo‐cardio‐facial syndrome, Am. J. Med. Genet., 42, 141, 10.1002/ajmg.1320420131
Sigurdsson T., 2010, Impaired hippocampal‐prefrontal synchrony in a genetic mouse model of schizophrenia, Nature, 464, 763, 10.1038/nature08855
Simon T.J., 2005, Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11. 2 deletion syndrome: an integrative study, Neuroimage, 25, 169, 10.1016/j.neuroimage.2004.11.018
Simon T.J., 2005, A multilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22q11. 2 deletion syndrome in children, Dev. Psychopathol., 17, 753, 10.1017/S0954579405050364
Sobin C., 2004, Networks of attention in children with the 22q11 deletion syndrome, Dev. Neuropsychol., 26, 611, 10.1207/s15326942dn2602_5
Sobin C., 2005, Neuropsychological characteristics of children with the 22q11 Deletion Syndrome: a descriptive analysis, Child Neuropsychol., 11, 39, 10.1080/09297040590911167
Sobin C., 2005, Lower prepulse inhibition in children with the 22q11 deletion syndrome, Am. J. Psychiatry, 162, 1090, 10.1176/appi.ajp.162.6.1090
Soldner F., 2009, Parkinson's disease patient‐derived induced pluripotent stem cells free of viral reprogramming factors, Cell, 136, 964, 10.1016/j.cell.2009.02.013
Spruston N., 2008, Pyramidal neurons: dendritic structure and synaptic integration, Nat. Rev. Neurosci., 9, 206, 10.1038/nrn2286
Stadtfeld M., 2010, Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells, Nature, 465, 175, 10.1038/nature09017
Stark K.L., 2008, Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11‐deletion mouse model, Nat. Genet., 40, 751, 10.1038/ng.138
Stefansson H., 2008, Large recurrent microdeletions associated with schizophrenia, Nature, 455, 232, 10.1038/nature07229
Styner M., 2005, Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease‐specific factors, Proc. Natl. Acad. Sci. U.S.A., 102, 4872, 10.1073/pnas.0501117102
Sun H., 2007, Shape‐based normalization of the corpus callosum for DTI connectivity analysis, IEEE Trans. Med. Imaging, 26, 1166, 10.1109/TMI.2007.900322
Suzuki G., 2009, Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice, Hum. Mol. Genet., 18, 1652, 10.1093/hmg/ddp086
Swerdlow N.R., 2001, Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges, Psychopharmacology (Berl), 156, 194, 10.1007/s002130100799
Swillen A., 1999, Neuropsychological, learning and psychosocial profile of primary school aged children with the velo‐cardio‐facial syndrome (22q11 deletion): evidence for a nonverbal learning disability?, Child Neuropsychol., 5, 230, 10.1076/0929-7049(199912)05:04;1-R;FT230
Sztriha L., 2004, Clinical, MRI, and pathological features of polymicrogyria in chromosome 22q11 deletion syndrome, Am. J. Med. Genet. A, 127, 313, 10.1002/ajmg.a.30014
Takarae Y., 2009, Catechol‐O‐methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome, Cogn. Affec. Behav. Neurosci., 9, 83, 10.3758/CABN.9.1.83
Tan G.M., 2009, Meta‐analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome), Schizophr. Res., 115, 173, 10.1016/j.schres.2009.09.010
Thomson J.M., 2006, Extensive post‐transcriptional regulation of microRNAs and its implications for cancer, Genes Dev., 20, 2202, 10.1101/gad.1444406
Tomari Y., 2005, MicroRNA biogenesis: drosha can't cut it without a partner, Curr. Biol., 15, R61, 10.1016/j.cub.2004.12.057
Triboulet R., 2009, Post‐transcriptional control of DGCR8 expression by the Microprocessor, RNA, 15, 1005, 10.1261/rna.1591709
Urban A.E., 2006, High‐resolution mapping of DNA copy alterations in human chromosome 22 using high‐density tiling oligonucleotide arrays, Proc. Natl. Acad. Sci. U.S.A., 103, 4534, 10.1073/pnas.0511340103
Usiskin S.I., 1999, Velocardiofacial syndrome in childhood‐onset schizophrenia, J. Am. Acad. Child Adolesc. Psychiatry, 38, 1536, 10.1097/00004583-199912000-00015
Amelsvoort T., 2004, Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study, Arch. Gen. Psychiatry, 61, 1085, 10.1001/archpsyc.61.11.1085
Essen D.C., 2006, Symmetry of cortical folding abnormalities in Williams syndrome revealed by surface‐based analyses, J. Neurosci., 26, 5470, 10.1523/JNEUROSCI.4154-05.2006
Vijayraghavan S., 2007, Inverted‐U dopamine D1 receptor actions on prefrontal neurons engaged in working memory, Nat. Neurosci., 10, 376, 10.1038/nn1846
Walsh T., 2008, Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia, Science, 320, 539, 10.1126/science.1155174
Wang P.P., 2000, Research on behavioral phenotypes: velocardiofacial syndrome (deletion 22q11.2), Dev. Med. Child Neurol., 42, 422
Wernicke C., 1906, Grundrisse der Psychiatrie
Wernig M., 2008, Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease, Proc. Natl. Acad. Sci. U.S.A., 105, 5856, 10.1073/pnas.0801677105
Willis A., 2008, PRODH variants and risk for schizophrenia, Amino Acids, 35, 673, 10.1007/s00726-008-0111-0
Wilson K.D., 2009, MicroRNA profiling of human‐induced pluripotent stem cells, Stem Cells Dev., 18, 749, 10.1089/scd.2008.0247
Woodin M., 2001, Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion, Genet. Med., 3, 34, 10.1097/00125817-200101000-00008
Wu J., 2006, Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression, Genome Biol., 7, R85, 10.1186/gb-2006-7-9-r85
Wu Y., 2010, Induced multilineage differentiation of chicken embryonic germ cells via embryoid body formation, Stem Cells Dev., 19, 195, 10.1089/scd.2008.0383
Xu B., 2008, Strong association of de novo copy number mutations with sporadic schizophrenia, Nat. Genet., 40, 880, 10.1038/ng.162
Xu B., 2009, Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans, Proc. Natl. Acad. Sci. U.S.A., 106, 16746, 10.1073/pnas.0908584106
Yagi H., 2003, Role of TBX1 in human del22q11.2 syndrome, Lancet, 362, 1366, 10.1016/S0140-6736(03)14632-6
Yavich L., 2007, Site‐specific role of catechol‐O‐methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum, J. Neurosci., 27, 10196, 10.1523/JNEUROSCI.0665-07.2007